3rd Quarter - Report — MAYO CLINIC for MAYO CLINIC (2021)

Firm

MAYO CLINIC

Client

MAYO CLINIC

Income

—

Expenses

$180,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Telemedicine and acute care at home; Laboratory Medicine payment and oversight, Medical research programs and funding; COVID/pandemic response

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Telemedicine and acute care at home waivers

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Support of clinical trials and research related to COVID-19; laboratory medicine

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Science/Technology SCI

New diagnostic tests, Broadband expansion and Internet access;

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.